G-Rich Oligonucleotides for Cancer Treatment
Oligonucleotides with guanosine-rich (G-rich) sequences often have unusual physical and biological properties, including resistance to nucleases, enhanced cellular uptake, and high affinity for particular proteins. Furthermore, we have found that certain G-rich oligonucleotides (GROs) have antiproliferative activity against a range of cancer cells, while having minimal toxic effects on normal cells. We have investigated the mechanism of this activity and studied the relationship between oligonucleotide structural features and biological activity. Our results indicate that the antiproliferative effects of GROs depend on two properties: the ability to form quadruplex structures stabilized by G-quartets and binding affinity for nucleolin protein. Thus, it appears that the antiproliferative GROs are acting as nucleolin aptamers. Because nucleolin is expressed at high levels on the surface of cancer cells, where it mediates the endocytosis of various ligands, it seems likely that nucleolin-dependent uptake of GROs plays a role in their activity. One of the GROs that we have developed, a 26-nucleotide phosphodiester oligodeoxynucleotide now named AS1411 (formerly AGRO100 or GRO26B-OH), is currently being tested as an anticancer agent in Phase II clinical trials.
- Detecting Mismatch Repair Defects in Myeloma
- Radial Monolayer Cell Migration Assay
- Detection of K-ras and p53 Mutations by Mutant-Enriched PCR-RFLP
- Breast Cancer Proteomics Using Two-Dimensional Electrophoresis: Studying the Breast Cancer Proteome
- Analyzing Markers of Apoptosis In Vitro
- Tumor Suppressor Gene-Inducible Cell Lines
- Cell Motility, Adhesion, Homing, and Migration Assays in the Studies of Tyrosine Kinases
- Methods to Analyze the Effects of the Urokinase System on Cancer Cell Adhesion, Proliferation, Migration, and Signal Transductio
- Gene Gun Delivery Systems for Cancer Vaccine Approaches
- Bisulfite Pyrosequencing